Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 3
R&D Momentum
56/100
Pipeline Velocity
19/100
Trial Completion Rate
100/100
Pipeline Concentration
33/100
Pipeline Freshness
17/100
Strategic Signals
Activity
Last 14 days
Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Omega-3 Fatty Acid (O3FA) Supplementation for Adult and Juvenile Dermatomyositis (DM/JDM)
Natural History of The Human Biological Response to Environmental Exposure and Injury
Factors Influencing Fertility or Pregnancy Health
Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies
Natural History of Asthma With Longitudinal Environmental Sampling
Study of the Effect of Innate Immunity on the Inflammatory Response to Endotoxin
Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders
Environmental Risk Factors for the Development of Myositis in Military Personnel
CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)